Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

28.5K
Overview
28.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
Allergic Drug Reactions01:27

Allergic Drug Reactions

971
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
971
Antibody Structure01:10

Antibody Structure

61.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.2K
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

453
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
453

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allergenicity assessment of novel foods - lessons from immune endotyping of food-allergic patients.

Frontiers in immunology·2026
Same author

ZFP36L1 and ZFP36L2 cooperatively regulate thymic epithelial cell function to prevent early-onset thymic involution.

Cell death and differentiation·2026
Same author

Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness.

Trends in cancer·2026
Same author

MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

Signal transduction and targeted therapy·2026
Same author

KLF2 controls thymic epithelial cell homeostasis, impacting regulatory T cell development and immune tolerance.

iScience·2026
Same author

Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes.

Hepatology (Baltimore, Md.)·2026

Related Experiment Video

Updated: Sep 8, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K

Fish Allergenicity Modulation Using Tailored Enriched Diets-Where Are We?

Denise Schrama1,2, Rebecca Czolk3,4, Cláudia Raposo de Magalhães1,2

  • 1Centre of Marine Sciences (CCMAR), Universidade do Algarve, Faro, Portugal.

Frontiers in Physiology
|June 13, 2022
PubMed
Summary
This summary is machine-generated.

Researchers modified fish diets to alter beta-parvalbumin, a major fish allergen. This strategy reduced allergic reactions in patients by 50% in gilthead seabream, offering hope for managing fish allergies.

Keywords:
EDTAcreatinefish allergiesfish nutritionparvalbumin

More Related Videos

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

16.5K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

Related Experiment Videos

Last Updated: Sep 8, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

16.5K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

Area of Science:

  • Food allergy research
  • Immunology
  • Fish nutrition

Background:

  • Food allergy is a significant health issue with increasing prevalence.
  • Fish allergy is common, with beta-parvalbumin identified as the primary allergen.
  • Current management of fish allergy relies on avoidance.

Purpose of the Study:

  • To investigate a novel strategy for reducing fish allergenicity.
  • To explore dietary modifications targeting beta-parvalbumin expression and conformation.
  • To assess the impact of these modifications on allergic reactions.

Main Methods:

  • Dietary intervention in fish (gilthead seabream) to modify beta-parvalbumin.
  • Induction of the apo-form of beta-parvalbumin.
  • Measurement of IgE-reactivity in fish-allergic patients.

Main Results:

  • Dietary modification successfully altered beta-parvalbumin.
  • Induction of the apo-form of beta-parvalbumin was achieved.
  • A 50% reduction in IgE-reactivity was observed in patients allergic to gilthead seabream.

Conclusions:

  • Dietary strategies can effectively reduce the allergenicity of fish.
  • Targeting beta-parvalbumin offers a promising approach to manage fish allergies.
  • This research opens new avenues for developing hypoallergenic fish products.